Welcome!

News Feed Item

Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System

MINNEAPOLIS, Jan. 28, 2014 /PRNewswire/ -- Nonin Medical, a leader in noninvasive medical monitoring, today announced that it has entered into a multi-year distribution agreement with Terumo Cardiovascular Group in Europe. As of January 2014, Terumo Cardiovascular Group will distribute Nonin's SenSmart™ Universal Oximetry System to all hospitals in the UK and Ireland. A similar distribution agreement between the two companies for the United States was announced in April 2013. Terumo manufactures and markets medical devices for the global cardiac surgery market.

(Photo: http://photos.prnewswire.com/prnh/20140128/CG54340)

The Nonin SenSmart Universal Oximetry System is the first dedicated oximeter system that provides measurements of both regional oximetry (rSO2) and pulse oximetry (SpO2). While providing industry-leading rSO2 accuracy,* the SenSmart system provides comprehensive monitoring of up to six-channels of rSO2 and SpO2 monitoring. No other oximeter system provides more than four channels of monitoring. The signal processor is substantially smaller than previous versions, making the SenSmart system ideal for use in a variety of settings where space is an issue, such as neonatal incubators. The system allows anesthesiologists, perfusionists, cardiovascular surgeons, neonatologists, intensivists, and other clinicians to quickly react to reverse tissue ischemia events before they become critical.

"Nonin Medical is pleased that this agreement, which takes advantage of Terumo's extensive cardiovascular relationships in heart hospitals in the UK and Ireland, will accelerate the adoption of the SenSmart System in the UK and Ireland," said Chris Holland, Vice President of Business Development for Nonin Medical. "Nonin's SpO2 and rSO2 technologies are cost-effective monitoring tools that help aid clinicians in caring for their patients with early detection of potentially dangerous events."

"Terumo UK is extremely excited about this collaboration with Nonin Medical and the opportunity it provides to both our current and new customers by adding their state-of-the-art regional oximetry to our current range of inline patient monitoring technologies," said Terumo UK Branch Manager Graham Walker. "We believe that this new addition to our product portfolio will be seen as a further indication of our commitment to provide the latest technology available to the UK cardiovascular market." 

Cardiovascular surgery is a common procedure in the UK and Ireland.  Regional oximetry-monitored procedures typically allow for early indication of oxygen desaturation that could lead to stroke, neurocognitive decline and other neurological or major organ injuries resulting from inadequate oxygen saturation. Regional oximetry solutions have been shown to reduce the cost of post-operative care and improve patient outcomes.[1]

Advantages of the SenSmart Universal Oximetry System include:

  • Versatile: The SenSmart system provides clinicians the ability to use Nonin SenSmart-compatible rSO2 sensors and/or SpO2 sensors to monitor up to six sites on neonatal, pediatric and adult patients.
  • Highly Accurate: The SenSmart System's EQUANOX™ Advance rSO2 Sensor provides clinicians with state-of-the-art accuracy. Nonin's reusable SpO2 Soft Sensors provide fast, accurate and reliable readings even in patients with low perfusion or in the presence of motion.
  • Easy to Use: The smaller, lighter and less-intrusive SenSmart Universal Signal Processors automatically recognize and display either the rSO2 or SpO2 signal, as well as the colored channel number you have chosen to connect to.
  • Convenient: The portable, easy-to-operate SenSmart Monitor offers Bluetooth® wireless connectivity and comes with SenSmart Download Software.
  • Pediatric-Specific Spacing of Light Emitters and Detectors: Designed specifically for patients weighing less than 40 kg with varying levels of myelination.

For more information about the Nonin SenSmart System, visit www.sensmart.com.

About Nonin Medical, Inc.

Nonin Medical, Inc. invented the finger pulse oximeter and designs and manufactures noninvasive medical monitoring solutions that meet customers' technology needs today and tomorrow. Headquartered in Minneapolis, Minn., with a customer center in Amsterdam, the Netherlands, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company also has more than 200 OEM partners worldwide. For more information, visit www.nonin.com.

About Terumo Europe Cardiovascular Systems

Terumo Europe Cardiovascular Systems is an integral part of the Terumo's family of cardiovascular businesses and is committed to developing innovative technologies for the treatment of cardiovascular disease. In Europe, Terumo Cardiovascular Systems provides products and service such as Capiox® Oxygenators, customized Tubing Sets, CDI® Blood Parameter Monitoring System, Pall® filter brand products, VirtuoSaph Plus®, the Endoscopic Vein Harvesting System. For more information, visit www.terumo-europe.com.

About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve.

* Accuracy data based on 8004CA sensor clinical results.

Reference:

[1.] Goldman SM, Sutter FP, Wertan MA, et al. Outcome improvement and cost reduction in an increasingly morbid cardiac surgery population. Semin Cardiothorac Vasc Anesth 2006;10:171-5.

©2014 Terumo Cardiovascular Systems Corporation. Terumo® is a trademark of Terumo Corporation. SenSmart™ and EQUANOX™ are trademarks of Nonin Medical, Inc. Bluetooth® is a trademark of Bluetooth SIG.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Announcing Poland #DigitalTransformation Pavilion
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...
CloudEXPO | DXWorldEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. All In Mobile is a mobile app development company from Poland. Since 2014, they maintain passion for developing mobile applications for enterprises and startups worldwide.
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
For far too long technology teams have lived in siloes. Not only physical siloes, but cultural siloes pushed by competing objectives. This includes informational siloes where business users require one set of data and tech teams require different data. DevOps intends to bridge these gaps to make tech driven operations more aligned and efficient.
The best way to leverage your CloudEXPO | DXWorldEXPO presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering CloudEXPO | DXWorldEXPO will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at CloudEXPO. Product announcements during our show provide your company with the most reach through our targeted audienc...
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors!
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...